Picton Mahoney Asset Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-604	Closed	-$21K	–	991
2025 Q1	$21K	Buy	604 +311	+106%	+$10.8K	﹤0.01%	539
2024 Q4	$16K	Buy	+293	New	+$16K	﹤0.01%	507